+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Cloning Services Market by Service Type, Application, End User, Technology Used, Source - Global Forecast to 2030- Product Image
Gene Cloning Services Market by Service Type, Application, End User, Technology Used, Source - Global Forecast to 2030- Product Image
Sale

Gene Cloning Services Market by Service Type, Application, End User, Technology Used, Source - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925088
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Cloning Services Market grew from USD 2.63 billion in 2024 to USD 2.95 billion in 2025. It is expected to continue growing at a CAGR of 12.22%, reaching USD 5.25 billion by 2030.

Pioneering Gene Cloning Services to Propel Life Science Innovations

The landscape of molecular biology has been profoundly transformed by advances in gene cloning services, establishing a cornerstone for breakthroughs in agriculture, medicine, and industrial biotechnology. This executive summary introduces the critical drivers and emerging trends that define the current environment for providers and end users of gene cloning solutions. By unpacking the technological, regulatory, and economic factors shaping demand for gene synthesis, mutagenesis, subcloning, and vector construction, the report equips stakeholders with a strategic vantage point.

Through a synthesis of expert insights and market intelligence, readers will gain clarity on how evolving customer needs and scientific innovations converge to create new opportunities. This introduction sets the stage for a deep dive into transformative shifts, tariff impacts, segmentation dynamics, regional highlights, competitive positioning, and actionable recommendations. Decision makers will emerge better prepared to navigate complexity and accelerate research and development objectives across diverse applications.

Transformations Reshaping the Gene Cloning Landscape

A surge in precision genome engineering techniques is reshaping expectations for gene cloning outcomes. Recent breakthroughs in CRISPR-based methodologies have elevated site-directed mutagenesis to unprecedented levels of accuracy, reducing off-target effects and shortening experiment timelines. Simultaneously, automation platforms are integrating with next-generation sequencing and AI-driven design tools, enabling streamlined workflows for de novo synthesis and codon optimization.

The convergence of digital lab environments with cloud-enabled data management is fostering real-time collaboration, allowing distributed teams to accelerate vector construction projects without compromising data integrity. Moreover, sustainability considerations are prompting providers to reduce reagent waste and adopt green chemistry practices. In parallel, the trend toward personalized therapeutics is driving demand for bespoke cloning services tailored to individualized treatment regimens. These transformative shifts collectively underscore the critical importance of flexible, scalable, and technology-forward solutions in the competitive gene cloning arena.

Assessing the Cumulative Impact of U.S. Tariffs in 2025 on Gene Cloning Trade

The imposition of new U.S. tariffs in 2025 on imported plasmids, enzymes, and specialized consumables has introduced additional cost pressures across the gene cloning supply chain. Providers faced with elevated import duties are exploring localization strategies to mitigate price increases for research institutions and commercial laboratories. As sourcing costs rise, customers are seeking greater transparency on pricing and lead times, prompting service providers to reevaluate inventory management and contractual terms.

In response, some vendors are negotiating long-term agreements with domestic manufacturers or investing in in-house reagent production to preserve margins and ensure supply continuity. The tariffs have also triggered discussion around regulatory reciprocity and the potential reclassification of certain materials under preferential trade frameworks. While short-term disruptions are evident, proactive stakeholders are leveraging tariff-driven realignments to strengthen regional supply networks and enhance resilience against future trade policy shifts.

Unveiling Market Segmentation Dynamics Fueling Gene Cloning Growth

A nuanced understanding of how service offerings align with customer objectives is essential for providers seeking to differentiate in a crowded field. Within the gene synthesis umbrella, codon optimization has seen accelerated uptake as customers prioritize expression yields and protein folding efficiency. De novo synthesis remains critical for constructing novel sequences, while fragment assembly workflows support rapid prototyping of genetic constructs. In the realm of mutagenesis, site-directed approaches are favored for precision edits, even as random mutagenesis retains relevance for library generation and functional screening.

Across applications, drug discovery and development consistently emerges as a high-growth segment, where functional analysis, lead optimization, and target validation services integrate seamlessly with cloning capabilities to expedite preclinical pipelines. Medical diagnostics leverages subcloning and vector construction to develop novel assay platforms, whereas agricultural biotechnology demands robust synthesis of transgenic elements. Academic and research institutes continue to account for a large share of service volume, but contract research organizations are rapidly expanding capacity to support biopharma clients. Hospitals and diagnostic laboratories increasingly rely on vector construction for gene therapy and molecular pathology, and large pharmaceutical companies maintain strategic partnerships with specialized service providers. Small and medium biotech firms, in turn, seek agile providers that offer turnkey solutions and rapid turnaround times.

From a technological standpoint, recombinant cloning methods-enhanced by Gateway and In-Fusion systems-are gaining traction due to their modularity and high-throughput compatibility. Golden Gate and Gibson Assembly workflows complement traditional restriction enzyme cloning, while TA Cloning remains a cost-effective option for quick inserts. Source preferences reveal outsourcing as the prevailing model, driven by contract research organizations and third-party service providers that offer specialized expertise and global reach. Nevertheless, many industry facilities and university core labs retain strong in-house capabilities to support ongoing discovery programs and academic curricula.

Regional Perspectives Highlighting Unique Gene Cloning Opportunities

Regional market dynamics in the Americas are characterized by mature infrastructure, significant R&D budgets, and a dense network of biotechnology clusters. Providers here benefit from well-established regulatory pathways and strong collaboration between industry and government agencies. In the Europe, Middle East & Africa corridor, demand is fueled by diverse pockets of innovation-from academic centers in Western Europe to emerging biotech hubs in the Gulf region-while regulatory harmonization efforts continue to facilitate cross-border research initiatives.

The Asia-Pacific region stands out for its rapid expansion, driven by growing domestic biopharmaceutical investment in China and India, and increasing government incentives for life science research in Southeast Asian markets. This ecosystem growth is spurring substantial capacity additions from both global service providers and local startups. Across all regions, the interplay of regulatory frameworks, funding environments, and collaborative networks shapes distinct opportunity profiles for gene cloning service providers seeking geographic diversification and market penetration.

Critical Company Profiles Driving Competitive Edge in Gene Cloning

Leading companies in gene cloning services demonstrate a multifaceted approach to sustaining competitive advantage through continuous innovation and strategic partnerships. Several market incumbents have broadened their portfolios by integrating automated synthesis platforms with AI-driven design algorithms, enabling seamless end-to-end solutions. Others pursue targeted acquisitions of niche specialists to enhance capabilities in high-value areas such as high-fidelity mutagenesis and advanced vector libraries.

Collaborations between industry leaders and academic institutions have yielded joint development programs that accelerate the translation of emerging technologies into commercial offerings. Additionally, providers are investing in expanding global footprints by establishing new laboratories in growth markets and forging alliances with regional distributors. The emphasis on quality management and regulatory compliance remains paramount, with ISO certifications and rigorous validation protocols serving as key differentiators for firms seeking to build long-term customer trust.

Strategic Recommendations to Strengthen Market Positioning

To capitalize on evolving market conditions, providers should prioritize investments in automation and digital integration, enabling scalable operations with consistent quality outputs. Diversification of supply chains through strategic alliances with regional reagent manufacturers can offset tariff-related risks and shorten procurement cycles. Embracing AI-powered design platforms will provide a competitive edge in codon optimization and construct validation, reducing development timelines.

Providers are also advised to strengthen collaborations with contract research organizations and university core facilities to expand service reach and capture adjacent research budgets. Offering flexible pricing and bundled service models can attract small and medium biotech firms with limited capital. Finally, a focus on sustainability-through reduced reagent waste and eco-friendly protocols-will resonate with customers seeking to align with environmental, social, and governance objectives.

Rigorous Research Methodology Underpinning the Analysis

This analysis draws upon a robust research framework combining secondary intelligence and primary interviews. Secondary inputs included peer-reviewed journals, patent filings, industry white papers, and regulatory filings, ensuring a comprehensive understanding of technological advances and policy shifts. Primary research involved in-depth discussions with executives from service providers, end user laboratories, and trade associations to capture firsthand perspectives on market dynamics.

Data triangulation techniques were employed to validate key findings, cross-referencing quantitative metrics with qualitative insights. Regional case studies and competitive benchmarking provided context for strategic assessments, while a panel of subject matter experts reviewed the methodology and conclusions to ensure rigor and impartiality. All data sources and analytical procedures adhere to high standards of transparency and reproducibility.

Synthesis of Insights to Guide Stakeholders Forward

The synthesis of technological, economic, and regulatory insights paints a clear picture of a gene cloning market poised for continued evolution. Advances in automation, AI integration, and sustainable practices are redefining service expectations, while geopolitical factors such as tariffs reinforce the importance of supply chain resilience. Segmentation analysis highlights the interplay of service types, applications, end user demands, and technology preferences, revealing targeted growth pockets and strategic entry points.

Regional variations underscore the necessity of tailored market approaches, and competitive profiling illustrates the value of innovation partnerships and operational excellence. By acting on the actionable recommendations outlined herein, industry stakeholders can secure a leading position in a dynamic and high-potential domain. The convergence of scientific ambition and market opportunity ensures that gene cloning services will remain foundational to breakthroughs across life sciences.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Service Type
    • Gene Synthesis
      • Codon Optimization
      • De Novo Synthesis
      • Fragment Assembly
    • Mutagenesis
      • Random Mutagenesis
      • Site Directed Mutagenesis
    • Subcloning
    • Vector Construction
      • Gibson Assembly
      • Golden Gate Assembly
      • Recombinant Cloning
      • Restriction Enzyme Cloning
  • Application
    • Agricultural Biotechnology
    • Drug Discovery And Development
      • Functional Analysis
      • Lead Optimization
      • Target Validation
    • Medical Diagnostics
    • Research
  • End User
    • Academic And Research Institutes
    • Contract Research Organizations
    • Hospitals And Diagnostic Laboratories
    • Pharmaceutical And Biotechnology Companies
      • Large Pharma
      • Small And Medium Biotech Firms
  • Technology Used
    • Gibson Assembly
    • Golden Gate Assembly
    • Recombinant Cloning
      • Gateway
      • In-Fusion
    • Restriction Enzyme Cloning
    • TA Cloning
  • Source
    • In-House
      • Industry Facilities
      • University Core Labs
    • Outsourced
      • Contract Research Organizations
      • Third-Party Service Providers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Azenta, Inc.
  • BGI Genomics Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Cloning Services Market, by Service Type
8.1. Introduction
8.2. Gene Synthesis
8.2.1. Codon Optimization
8.2.2. De Novo Synthesis
8.2.3. Fragment Assembly
8.3. Mutagenesis
8.3.1. Random Mutagenesis
8.3.2. Site Directed Mutagenesis
8.4. Subcloning
8.5. Vector Construction
8.5.1. Gibson Assembly
8.5.2. Golden Gate Assembly
8.5.3. Recombinant Cloning
8.5.4. Restriction Enzyme Cloning
9. Gene Cloning Services Market, by Application
9.1. Introduction
9.2. Agricultural Biotechnology
9.3. Drug Discovery and Development
9.3.1. Functional Analysis
9.3.2. Lead Optimization
9.3.3. Target Validation
9.4. Medical Diagnostics
9.5. Research
10. Gene Cloning Services Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostic Laboratories
10.5. Pharmaceutical and Biotechnology Companies
10.5.1. Large Pharma
10.5.2. Small and Medium Biotech Firms
11. Gene Cloning Services Market, by Technology Used
11.1. Introduction
11.2. Gibson Assembly
11.3. Golden Gate Assembly
11.4. Recombinant Cloning
11.4.1. Gateway
11.4.2. in-Fusion
11.5. Restriction Enzyme Cloning
11.6. TA Cloning
12. Gene Cloning Services Market, by Source
12.1. Introduction
12.2. in-House
12.2.1. Industry Facilities
12.2.2. University Core Labs
12.3. Outsourced
12.3.1. Contract Research Organizations
12.3.2. Third-Party Service Providers
13. Americas Gene Cloning Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Gene Cloning Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Gene Cloning Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. QIAGEN N.V.
16.3.4. Agilent Technologies, Inc.
16.3.5. Eurofins Scientific SE
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Twist Bioscience Corporation
16.3.8. GenScript Biotech Corporation
16.3.9. Azenta, Inc.
16.3.10. BGI Genomics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENE CLONING SERVICES MARKET MULTI-CURRENCY
FIGURE 2. GENE CLONING SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. GENE CLONING SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENE CLONING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CODON OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY DE NOVO SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY FRAGMENT ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RANDOM MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SUBCLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GIBSON ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GOLDEN GATE ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RESTRICTION ENZYME CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY FUNCTIONAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SMALL AND MEDIUM BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GIBSON ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GOLDEN GATE ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GATEWAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY IN-FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY RESTRICTION ENZYME CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY TA CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY INDUSTRY FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY UNIVERSITY CORE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY THIRD-PARTY SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. CANADA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 88. CANADA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 89. CANADA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 90. CANADA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. CANADA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. CANADA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 95. CANADA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 96. CANADA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. CANADA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 98. CANADA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 99. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 105. MEXICO GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 108. MEXICO GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 109. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 165. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 169. GERMANY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. GERMANY GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 171. GERMANY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. GERMANY GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 173. GERMANY GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 174. GERMANY GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 175. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 178. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 182. FRANCE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. FRANCE GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. FRANCE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. FRANCE GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 186. FRANCE GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 187. FRANCE GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 188. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. FRANCE GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 190. FRANCE GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 204. ITALY GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. ITALY GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 206. ITALY GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 207. ITALY GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 208. ITALY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. ITALY GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 210. ITALY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ITALY GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 212. ITALY GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 213. ITALY GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 214. ITALY GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 215. ITALY GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 216. ITALY GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 217. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SPAIN GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 221. SPAIN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SPAIN GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. SPAIN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SPAIN GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. SPAIN GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 226. SPAIN GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 227. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. SPAIN GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 269. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 270. DENMARK GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 273. DENMARK GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. DENMARK GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 275. DENMARK GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. DENMARK GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 277. DENMARK GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 278. DENMARK GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 279. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 280. DENMARK GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 281. DENMARK GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 295. QATAR GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 296. QATAR GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 297. QATAR GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 298. QATAR GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 299. QATAR GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. QATAR GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 301. QATAR GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. QATAR GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 303. QATAR GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 304. QATAR GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 305. QATAR GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. QATAR GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 307. QATAR GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 308. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND GENE CLONING SERVICES MARKET SIZE, BY MUTAGENESIS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND GENE CLONING SERVICES MARKET SIZE, BY VECTOR CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 312. FINLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. FINLAND GENE CLONING SERVICES MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 314. FINLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. FINLAND GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 316. FINLAND GENE CLONING SERVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 317. FINLAND GENE CLONING SERVICES MARKET SIZE, BY RECOMBINANT CLONING, 2018-2030 (USD MILLION)
TABLE 318. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 319. FINLAND GENE CLONING SERVICES MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 320. FINLAND GENE CLONING SERVICES MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Cloning Services market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Azenta, Inc.
  • BGI Genomics Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.25 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
DNA and Gene Cloning Services - Global Strategic Business Report - Product Image

DNA and Gene Cloning Services - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
DNA And Gene Cloning Services Global Market Report 2025 - Product Image

DNA And Gene Cloning Services Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Gene Cloning Market

Gene Cloning is a process used in genomics to create copies of genes or other DNA fragments. It is used to produce large amounts of a particular gene or gene product for research or therapeutic purposes. The gene cloning market is driven by the increasing demand for gene-based therapies, the growing prevalence of genetic diseases, and the increasing use of gene-based diagnostics. The market is also driven by the increasing investments in genomics research and the increasing demand for personalized medicine. The gene cloning market is segmented into products, services, applications, and end-users. The products segment includes reagents, kits, enzymes, and other consumables. The services segment includes contract research services, sequencing services, and bioinformatics services. The applications segment includes drug discovery, diagnostics, and research. The end-users segment includes pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers. Some of the major companies in the gene cloning market are Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., Merck KGaA, QIAGEN, Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Takara Bio, Inc., and Lonza Group. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.